How brand-name manufacturers can get their drugs out the door faster.
Medication, Health Care Affordability Improved During COVID-19 Pandemic
Researchers compared health care and prescription medication affordability during the COVID-19 pandemic to pre-pandemic numbers.
GLP-1s, SGLT2 Inhibitors Reduce Progression of CKD
In a session presented at the 2024 Heart in Diabetes Conference, Matthew Weir, MD, discussed the potential benefits of GLP-1s and SGLT2 inhibitors for improved chronic kidney disease and cardiovascular outcomes.
Financial Incentives Show Significant Success for Weight Loss in Men
Researchers analyzed groups of men given financial incentives to motivate weight-loss behaviors compared with a non-incentivized control group.
FDA Approves Updated Label for Altuviiio for Effective Bleed Protection in Children Younger than 12 Years
Altuviiio was first granted approval by the FDA in February 2023.
Pharmacogenetic Testing Recommendations Needed in Clinical Guidelines to Increase Consistency
A review found that many guidelines that recommended pharmacogenetic testing were inconsistent between clinical associations.
Leqvio Gets Label Update For Earlier Use in Patients with Heart Disease
Recent safety data also allowed four adverse events to be removed from the label.
